EcoDrugPlus

Ensembl ID : ENSODEG00000020377
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSODEG00000010086
Gene Symbol: -
Cross references: -
288 Possible Orthologues:

Ensembl ID : ENSODEG00000000458
Gene Symbol: -
Cross references: -
325 Possible Orthologues:

Ensembl ID : ENSODEG00000015216
Gene Symbol: -
Cross references: -
325 Possible Orthologues:

Ensembl ID : ENSODEG00000018556
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSODEG00000020092
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSODEG00000020081
Gene Symbol: -
Cross references: -
91 Possible Orthologues:

Ensembl ID : ENSODEG00000018888
Gene Symbol: -
Cross references: -
313 Possible Orthologues:

Ensembl ID : ENSODEG00000018884
Gene Symbol: -
Cross references: -
382 Possible Orthologues:

Ensembl ID : ENSODEG00000013947
Gene Symbol: -
Cross references: -
288 Possible Orthologues:

Ensembl ID : ENSODEG00000012482
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSODEG00000011601
Gene Symbol: -
Cross references: -
382 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).